![igc-ad1 igc pharma](https://investor.igcpharma.com/wp-content/uploads/2024/04/PR-AD_02-min-1024x1024.jpg)
November 23, 2020
IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer’s Patients
Facebook
Twitter
LinkedIn